HQ Function

Prior to its acquisition by Merck, the headquarters served as the central hub for Harpoon's research and development, clinical operations, and corporate administration.

Notable Features:

Located within a modern biotechnology park, the facility likely featured advanced laboratory spaces, R&D equipment, and collaborative office environments suitable for a clinical-stage biopharmaceutical company.

Work Culture:

As a clinical-stage biotech, the work culture was likely dynamic, science-driven, and highly focused on innovation and achieving clinical milestones. Collaboration, agility, and a commitment to addressing unmet medical needs in oncology would have been key characteristics. Post-acquisition, employees and operations are integrated into Merck's corporate culture.

HQ Significance:

The South San Francisco location provided strategic advantages, including proximity to a rich talent pool, leading academic institutions, potential collaborators, and a vibrant biotech ecosystem.

Values Reflected in HQ: The headquarters would have reflected values such as scientific excellence, innovation, patient focus, and teamwork, essential for advancing novel cancer therapies.

Location:

Before being acquired by Merck, Harpoon Therapeutics' global functions were primarily focused on the execution of its clinical development programs. This involved managing clinical trial sites and collaborating with investigators and CROs in North America and potentially other international regions to advance its pipeline of T cell engagers. The company did not operate a widespread network of international offices; its strategic and operational oversight was centralized at its U.S. headquarters. Its assets and programs are now part of Merck's extensive global oncology operations.

Street Address:

131 Oyster Point Blvd, Suite 300

City:

South San Francisco

State/Province:

CA

Country:

USA